Ginkgo Bioworks shares were 6% higher, at $9.76, after the company said it has been awarded a four-year contract, worth up to $47 million, by the Environmental Molecular Sciences Laboratory at Pacific ...

BOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory ...

PNNL commissioned AMP2 prototype to automate microbial phenotyping and AI analysis. DOE awarded $47M to Ginkgo for a 32,000 sq ft M2PC facility to scale autonomy. Autonomous labs will speed ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Queen Mary’s Prof Costantino Pitzalis and Prof Myles Lewis have invented a new way to predict the best biological therapy for rheumatoid arthritis patients. Their method uses deep molecular ...

Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Effect of antibiotic, proton pump inhibitor, H2 blocker, metformin and statin use on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a ...

Ginkgo Bioworks shares were 6% higher, at $9.76, after the company said it has been awarded a four-year contract, worth up to $47 million, by the Environmental Molecular Sciences Laboratory at Pacific ...